Article
Foresight in clinical proteomics: current status, ethical considerations, and future perspectives
2023-11-01
Abstract excerpt
With the advent of robust and high-throughput mass spectrometric technologies and bioinformatics tools to analyze large data sets, proteomics has penetrated broadly into basic and translational life sciences research. More than 95% of FDA-approved drugs currently target proteins, and most diagnostic tests are protein-based. The introduction of proteomics to the clinic, for instance to guide patient stratification...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- f8680459-a3b6-5037-a297-f0bdc8a66040
- DOI
- 10.12688/openreseurope.15810.2
